Core Services: Investors

Evolution Bioscience’s thorough due diligence process encompasses a commercial viability assessment, intellectual asset analysis, financial appraisals and a comprehensive evaluation of the business plan and human capital involved. Ultimately the process seeks to enable effective decision making by providing investors with a clear understanding of the business proposition, capacity to deliver and the expected payback.

Numerous global investment opportunities pass our desks every day. Evolution Bioscience analysts specialise in carefully selecting opportunities that offer ‘reasonable’ risk vs. return profiles for investors seeking to strengthen their portfolio.

The Biotech markets are volatile and often irrational. Trading in the short term can overvalue or undervalue stock on the basis of supply vs. demand dynamics. We work with clients who wish to take a longer term view with regards to investment in biotech. This view is based on the market opportunity discounted for risk rather than unpredictable, fluctuating MarCap values.

At Evolution we pride ourselves on sourcing elite candidates using live market intelligence rather than searching through an outdated CV database. Our sister company, Evolution Global Talent Attraction, approaches each role individually, generating a bespoke plan of action to ensure our clients attract, hire and retain the best talent the industry has to offer.